β-amyloid fibrils activate the C1 complex of complement under physiological conditions: Evidence for a binding site for Aβ on the C1q globular regions

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6374-6381

  Tacnet Delorme, P ^a   Chevallier, S ^a   Arlaud, G J ^a  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION;

EID: 0035575742     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6374     Document Type: Article

References (54)

1. The molecular pathology of Alzheimer's disease
2. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
3. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage
4. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
5. Immunoglobulins and complement factors in senile plaques
6. Cytokines and inflammatory proteins in Alzheimer's disease
7. Cerebrospinal fluid antibodies: An indicator for immune response in Alzheimer's disease
8. Immuno-electron microscopic localization of complement in amyloid fibrils of senile plaques
9. Immune system response in Alzheimer's disease
10. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain
11. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide
12. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation
13. Complement components of the innate immune system in health and disease in the CNS
14. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells
15. Complement activation by β-amyloid in Alzheimer disease
16. β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q-A chain
17. Multivalent binding of complement protein C1q to the amyloid/β-peptide (Aβ) promotes the nucleation phase of Aβ aggregation
18. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: Complement activation and therapeutic approaches
19. Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis
20. Charge-based binding of complement component C1q to the Alzheimer amyloid β-peptide
21. The classical complement pathway: Activation and regulation of the first complement component
22. The atypical serine proteases of the complement system
23. C1q: Structure, function, and receptors
24. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q
25. DNA binds and activates complement via residues 14-26 of the human C1q-A chain
26. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q
27. A simplified procedure for the purification of C1-inactivator from human plasma
28. Differential elution of C1q, C1r and C1s from human C1 bound to immune aggregates: Use in the rapid purification of C1 subcomponents
29. Purification and radiolabeling of human C1q
30. Purified proenzyme C1r: Some characteristics of its activation and subsequent proteolytic cleavage
31. In vitro analysis of complement-dependent HIV-1 cell infection using a model system
32. Human complement serine proteases C1r and C1s and their proenzymes
33. Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent C1q of the first component of human complement
34. Measurements of the association constants of the complexes formed between intact C1q or pepsin-treated C1q stalks and the unactivated or activated C1r2C1s2 tetramers
35. Chemical studies of the isolated collagen-like and globular fragments of complement component C1q: Comparative studies on bovine and human C1q
36. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1
37. Location of the binding site in subcomponent C1q for plasma fibronectin
38. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
39. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
40. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s
41. Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase
42. A new role for C1-inhibitor in homeostasis: Control of activation of the first component of human complement
43. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41
44. Electron microscopy of prefibrillar structures and amyloid fibrils
45. Translating cell biology into therapeutic advances in Alzheimer's disease
46. Amino-terminal deletions enhance aggregation of β-amyloid peptide in vitro
47. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
48. Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation
49. Aggregation state-dependent activation of the classical complement pathway by the amyloid β peptide
50. Complement activation by cross-linked truncated and chimeric full-length β-amyloid
51. The binding site for C1q on IgG
52. Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G
53. The physiological structure of human C-reactive protein and its complex with phosphocholine
54. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate similar, but not identical, binding specificities for polyanionic ligands